A Phase I, Open-Label, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intra-anal Application of Topical Oxymetazoline Gel in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Oxymetazoline (Primary)
- Indications Faecal incontinence
- Focus Pharmacokinetics
- Sponsors RDD Pharma
- 27 Nov 2018 Planned End Date changed from 30 Nov 2018 to 31 Mar 2019.
- 27 Nov 2018 Planned primary completion date changed from 31 Oct 2018 to 28 Feb 2019.
- 21 Oct 2018 Planned End Date changed from 1 Sep 2018 to 30 Nov 2018.